Forty patients (23.1%) had SLEDAI >= 6 at baseline and none, except one, had an increase in SLEDAI.Conclusions: The pandemic vaccine is safe in SLE patients regardless of disease activity but seroconversion is lower than in healthy subjects, particularly in patients under MMF therapy.